RxDoctor Payments Data

Jodie Warsing

Nurse Practitioner · Saint Louis, MONPI 1639116767

Payments from drug & device makers

$1,274in general payments, 2019–2025

Across 63 payments — averaging $20.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$408
  • AbbVie$183
  • Otsuka America Pharmaceutical, Inc.$163
  • Alkermes, Inc.$156
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$132
  • Neurocrine Biosciences, Inc.$98
  • plus $134 from 4 others

What the payments were for

  • Food & beverage$1,19994%
  • Education$756%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,274 in reported general payments places this provider in the 75th percentile of 1,898 nurse practitioner providers in Missouri.

See all nurse practitioner providers in Missouri

Medicare billing

Part B allowed, 2024
$11,104
Medicare patients
23
Services billed
112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate83$240,237
AristadaAripiprazole Lauroxil16$48,786
Abilify MaintenaAripiprazole15$43,828
VraylarCariprazine Hcl46$32,063
Paliperidone ErPaliperidone72$18,076
TrintellixVortioxetine Hydrobromide15$7,180
Clozapine52$4,776
Aripiprazole78$4,520
Quetiapine Fumarate116$2,073
Trazodone Hcl185$1,967
Olanzapine148$1,785
Duloxetine Hcl58$1,733
Naltrexone Hcl35$1,207
Venlafaxine Hcl ErVenlafaxine Hcl17$1,065
Hydroxyzine Hcl52$976

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$408$240,23783 claims
Alkermes, Inc.Aristada$156$48,78616 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$163$43,82815 claims
AbbVieVraylar$183$32,06346 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$25$7,18015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,898 nurse practitioner providers in Missouri.

Other nurse practitioner in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →